| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,673 |
19,917 |
$978K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,561 |
7,375 |
$556K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,562 |
5,931 |
$414K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,567 |
5,947 |
$409K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,037 |
4,474 |
$339K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,957 |
4,665 |
$294K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17,504 |
15,437 |
$223K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
10,852 |
9,780 |
$149K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,574 |
2,289 |
$122K |
| 99460 |
|
2,347 |
2,109 |
$96K |
| 54150 |
|
826 |
695 |
$93K |
| 92551 |
|
11,854 |
10,542 |
$84K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,453 |
2,090 |
$59K |
| 99462 |
|
1,883 |
1,679 |
$41K |
| 85018 |
|
19,105 |
15,689 |
$35K |
| 90474 |
|
3,503 |
3,164 |
$29K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
319 |
285 |
$22K |
| 83655 |
|
2,325 |
1,807 |
$20K |
| 99173 |
|
12,614 |
11,020 |
$20K |
| 81003 |
|
10,662 |
8,565 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
602 |
476 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
855 |
714 |
$9K |
| 99464 |
|
156 |
139 |
$8K |
| 0002A |
|
321 |
163 |
$7K |
| 0001A |
|
184 |
136 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
564 |
454 |
$5K |
| 87807 |
|
432 |
365 |
$5K |
| 0071A |
|
162 |
101 |
$4K |
| 0072A |
|
102 |
91 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
56 |
25 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
81 |
64 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
17 |
12 |
$836.28 |
| 0003A |
|
21 |
15 |
$751.70 |
| 90620 |
|
1,123 |
919 |
$570.00 |
| 96160 |
|
724 |
602 |
$411.84 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
116 |
101 |
$402.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
37 |
$382.12 |
| 69210 |
|
22 |
17 |
$351.86 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
16 |
12 |
$90.00 |
| 90670 |
|
4,290 |
4,043 |
$72.00 |
| 90686 |
|
3,623 |
3,217 |
$60.28 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
25 |
$50.56 |
| 90651 |
|
2,108 |
1,867 |
$42.45 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
57 |
52 |
$38.22 |
| 90734 |
|
1,218 |
1,054 |
$13.52 |
| 90633 |
|
2,492 |
2,224 |
$0.05 |
| 90671 |
|
362 |
303 |
$0.01 |
| 90648 |
|
565 |
522 |
$0.00 |
| 90710 |
|
552 |
477 |
$0.00 |
| 90715 |
|
546 |
476 |
$0.00 |
| 90700 |
|
527 |
487 |
$0.00 |
| 90707 |
|
604 |
527 |
$0.00 |
| 90685 |
|
828 |
778 |
$0.00 |
| 90681 |
|
34 |
30 |
$0.00 |
| 91300 |
|
630 |
366 |
$0.00 |
| 90380 |
|
18 |
15 |
$0.00 |
| 3008F |
|
1,024 |
879 |
$0.00 |
| 90698 |
|
2,194 |
2,098 |
$0.00 |
| 90744 |
|
1,409 |
1,317 |
$0.00 |
| 91307 |
|
253 |
183 |
$0.00 |
| 90696 |
|
450 |
398 |
$0.00 |
| 90680 |
|
3,343 |
3,039 |
$0.00 |
| 90677 |
|
502 |
460 |
$0.00 |
| 90697 |
|
1,535 |
1,358 |
$0.00 |
| 99000 |
|
214 |
203 |
$0.00 |
| 90619 |
|
402 |
314 |
$0.00 |
| 90716 |
|
596 |
516 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.00 |